Leukenib Tablet

Leukenib Tablet 400 mg Introduction

Leukenib Tablet 400 mg is an antineoplastic medication used to treat certain types of leukemia and various other cancers. It belongs to a class of medications known as tyrosine-kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It is also used to treat gastrointestinal stromal tumors that cannot be treated with surgery.

Uses for

Leukenib Tablet 400 mg is used to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumor (GIST). It is also used to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), and some types of myeloproliferative neoplasms (MPN).

Brand Name	Leukenib
Type	Tablet
Weight	400 mg
Generic	Imatinib Mesylate
Manufacturer	Jenphar Bangladesh Ltd.
Available in	English বাংলা

Mechanism of Action

Leukenib Tablet 400 mg works by blocking the activity of mutant proteins that are responsible for the uncontrolled growth of cancer cells. It inhibits the enzyme tyrosine kinase, which is responsible for stimulating cell growth by transferring phosphate groups to proteins. Leukenib Tablet 400 mg blocks the action of this enzyme, which results in the suppression of cancer cell growth.

How Long Does It Take To Work

The effects of Leukenib Tablet 400 mg may be seen within weeks after starting the medication. However, it may take some time for the leukemia or other cancer to be completely brought under control depending on the severity of the condition.

Absorption

Leukenib Tablet 400 mg is rapidly absorbed and reaches peak plasma concentrations 1-2 hours after an oral dose. The plasma concentration decreases rapidly with a half-life of 3-7 hours.

Route of Elimination

Leukenib Tablet 400 mg is eliminated primarily via the liver and kidney. Approximately 90% of an administered dose is excreted in urine and feces within 48 hours.

Dosage

Adults with Ph+ CML CP: 400 mg/day
Adults with Ph+ CML AP or BC: 600 mg/day
Pediatrics with Ph+ CML CP: 340 mg/m2/day
Adults with Ph+ ALL: 600 mg/day
Pediatrics with Ph+ ALL: 340 mg/m2/day
Adults with MDS/MPD: 400 mg/day
Adults with ASM: 100 mg/day or 400 mg/day
Adults with HES/CEL: 100 mg/day or 400 mg/day
Adults with DFSP: 800 mg/day
Adults with metastatic and/or unresectable GIST: 400 mg/day
Adjuvant treatment of adults with GIST: 400 mg/day
Patients with mild to moderate hepatic impairment: 400 mg/day
Patients with severe hepatic impairment: 300 mg/day

All doses of Imatinib should be taken with a meal and a large glass of water. Doses of 400 mg or 600 mg should be administered once daily, whereas a dose of 800 mg should be administered as 400 mg twice a day. Imatinib can be dissolved in water or apple juice for patients having difficulty swallowing. Daily dosing of 800 mg and above should be accomplished using the 400-mg tablet to reduce exposure to iron.

The recommended dose of Leukenib Tablet 400 mg varies depending on the condition being treated. For adults with CML or Philadelphia chromosome-positive ALL, the usual dose ranges from 400mg to 600mg per day. For adults with GIST or myeloproliferative neoplasms, the recommended dose is 400mg per day. Dosage adjustment may be necessary for patients with renal impairment.

Administration

Leukenib Tablet 400 mg is taken orally once or twice daily, depending on the condition being treated. It should be taken on an empty stomach. It should be taken at the same time each day to maintain a steady drug level in the body.

Side Effects

Common side effects of Leukenib Tablet 400 mg include nausea, vomiting, muscle cramps, diarrhea, rash, fatigue, weakness, and headache. Serious side effects may include allergic reactions, increased risk of bleeding, liver damage, and fluid retention. Notify your doctor immediately if any of these side effects occur.

Toxicity

Leukenib Tablet 400 mg is generally well tolerated, but toxicity may occur in rare cases. Symptoms of overdose may include nausea, vomiting, diarrhea, loss of consciousness, and seizures. Patients should be monitored closely for signs of toxicity and seek medical attention immediately if any occur.

Precautions

Before using Leukenib Tablet 400 mg, tell your doctor if you have any allergies or are taking any other medications, especially blood thinners, nonsteroidal anti-inflammatory drugs, and antifungal medications. Leukenib Tablet 400 mg should not be used during pregnancy or breastfeeding unless the potential benefits outweigh the risks. It should also be used with caution in patients with liver or kidney disease.

Interaction

Leukenib Tablet 400 mg may interact with other medications or substances, such as alcohol, anti-coagulants, nonsteroidal anti-inflammatory drugs, or antifungal medications. It may also interact with certain foods, such as grapefruit and certain dairy products. Tell your doctor about all medications, vitamins, and supplements you are taking.

Disease Interaction

Leukenib Tablet 400 mg may interact with a number of medical conditions. It should be used with caution in patients with liver or kidney disease, and in those who have recently had a heart attack, or who have a history of congestive heart failure. It should also not be used by patients with a history of gastrointestinal bleeding.

Drug Interaction

Leukenib Tablet 400 mg may interact with a number of other medications, both prescription and over-the-counter. These include blood-thinning medications, nonsteroidal anti-inflammatory drugs, antifungal medications, and some antibiotics. Notify your doctor of any other medications you are taking.

Food Interactions

Leukenib Tablet 400 mg may interact with certain foods. Grapefruit and other citrus fruits may interact with Leukenib Tablet 400 mg and increase its levels in the body. Dairy products may interact with Leukenib Tablet 400 mg and decrease its absorption, so separate doses of the two should be taken. It is important to talk to your doctor before consuming grapefruit or other citrus fruits or dairy products.

Pregnancy Use

Leukenib Tablet 400 mg should not be used by pregnant women. It can cause harm to an unborn baby and should only be used if the potential benefits outweigh the risks. It is important to inform your doctor if you are pregnant or planning to become pregnant.

Lactation Use

Leukenib Tablet 400 mg should not be used by nursing mothers. It may pass into breast milk and cause harm to a nursing baby. Inform your doctor if you are breastfeeding or planning to do so.

Acute Overdose

Leukenib Tablet 400 mg should be used as prescribed by your doctor. Overdose may cause nausea, vomiting, diarrhea, decreased consciousness, and seizures. If an overdose is suspected, seek medical attention immediately.

Contraindication

Leukenib Tablet 400 mg should not be used in patients with severe liver or kidney disease, or in those with a history of gastrointestinal bleeding. It should also not be used by patients with a known hypersensitivity or an allergy to Leukenib Tablet 400 mg. Patients must also inform their doctor if they are pregnant or breastfeeding.

Use Direction

Leukenib Tablet 400 mg should be taken as prescribed by your doctor. The usual dose is 400 mg to 600 mg per day, taken orally with or without food. It is important to take the medication at the same time each day to maintain a steady level in the body.

Storage Condition

Leukenib Tablet 400 mg should be stored at room temperature, away from light, moisture, and heat. Keep the medication in a tightly closed container and out of reach of children.